Microbot to Attend SIR EDGE 2026 Conference to Discuss Liberty System
Microbot Medical announced executives will attend SIR EDGE 2026 to engage with physicians and hospital administrators. This participation aims to expand the company's national sales footprint and facilitate the commercialization of its FDA-cleared LIBERTY Endovascular Robotic System.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed